It also remains to be addressed if (non)selective BTK inhibition exerts the same global effects in non-CLL B cell neoplasms such as mantle cell lymphoma, marginal zone lymphoma, Waldenström’s macroglobulinemia, and others. Here, BTK is linked to B-cell chronic lymphocytic leukemia.